Cargando…

The participation of clinical pharmacists in the treatment of patients with central nervous system infection can improve the effectiveness and appropriateness of anti-infective treatments: a retrospective cohort study

Background: Central nervous system infection (CNSI) treatment in hospital neurosurgery emphasizes the importance of optimizing antimicrobial therapy. Timely and appropriate empiric antibiotic treatment is critical for managing patients with bacterial meningitis. Objectives: To evaluate the activitie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jie, Dang, ChuanDong, Li, Xiao, Wang, JianJun, Huang, Xin, Li, Yan, Cui, XueYan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512419/ https://www.ncbi.nlm.nih.gov/pubmed/37745082 http://dx.doi.org/10.3389/fphar.2023.1226333

Ejemplares similares

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
por: Zhu, Yingying, et al.
Publicado: (2021)

Pharmacist Remote Review of Medication Prescriptions for Appropriateness in Pediatric Intensive Care Unit
por: Lazaryan, Moran, et al.
Publicado: (2016)

Molecular imaging as a guide for the treatment of central nervous system disorders
por: Kim, Euitae, et al.
Publicado: (2013)

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
por: Liu, Shu-Ping, et al.
Publicado: (2022)

Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review
por: Liu, Yue, et al.
Publicado: (2022)

Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders
por: Hong, Hongxiang, et al.
Publicado: (2022)

Medicinal Cannabis and Central Nervous System Disorders
por: Ortiz, Yuma T., et al.
Publicado: (2022)

A Review on Central Nervous System Effects of Gastrodin
por: Liu, Yuan, et al.
Publicado: (2018)

What Is the Most Appropriate Induction Regimen for the Treatment of HIV-Associated Cryptococcal Meningitis When the Recommended Regimen Is Not Available? Evidence From a Network Meta-Analysis
por: Li, Yao, et al.
Publicado: (2020)

The Effectiveness of Clinical Pharmacist-Led Consultation in the Treatment of Infectious Diseases: A Prospective, Multicenter, Cohort Study
por: Zhang, Jiaxing, et al.
Publicado: (2020)

Evaluation of the Effectiveness of Clinical Pharmacists’ Consultation in the Treatment of Infectious Diseases: A Single-Arm, Prospective Cohort Study
por: Zhang, Jiaxing, et al.
Publicado: (2019)

Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis
por: Wu, Haiyang, et al.
Publicado: (2021)

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
por: Yu, Qingying, et al.
Publicado: (2021)

Treatment of non-tuberculosis mycobacteria skin infections
por: Wang, Xin-Yu, et al.
Publicado: (2023)

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System
por: Zhang, Haofuzi, et al.
Publicado: (2021)

Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
por: Qiu, Sha, et al.
Publicado: (2021)

Pharmacist-led iodinated contrast media infusion risk assessment service
por: Jiang, Huiyan, et al.
Publicado: (2023)

Axon growth inhibition by RhoA/ROCK in the central nervous system
por: Fujita, Yuki, et al.
Publicado: (2014)

The Case for TAAR1 as a Modulator of Central Nervous System Function
por: Rutigliano, Grazia, et al.
Publicado: (2018)

Role of TREK-1 in Health and Disease, Focus on the Central Nervous System
por: Djillani, Alaeddine, et al.
Publicado: (2019)

Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases
por: Tan, Qingyun, et al.
Publicado: (2021)

The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review
por: Silva dos Santos, Jéssica, et al.
Publicado: (2021)

Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases
por: Gong, Liang, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
por: German, Nadezhda A.
Publicado: (2023)

Clinical treatment of pandrug-resistant bacterial infection consulted by clinical pharmacist
por: Zhi-Wen, Yang, et al.
Publicado: (2015)

Efficient Treatment of Sporothrix globosa Infection Using the Antibody Elicited by Recombinant Phage Nanofibers
por: Chen, Feng, et al.
Publicado: (2019)

The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study
por: Du, Qian, et al.
Publicado: (2023)

Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
por: Lin, Guimiao, et al.
Publicado: (2017)

Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
por: Pittaluga, Anna
Publicado: (2016)

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
por: Pandey, Manisha, et al.
Publicado: (2022)

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross‐Sectional Study
por: Hu, Wen, et al.
Publicado: (2022)

Novel approaches and challenges to treatment of central nervous system viral infections
por: Nath, Avindra, et al.
Publicado: (2013)

Clinical Characteristics and Treatment of Listeria monocytogenes Infections in the Central Nervous System
por: Xu, Xiaojiao, et al.
Publicado: (2023)

Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma
por: Mao, Junjun, et al.
Publicado: (2022)

Visualizing the Potential Impairment of Polymyxin B to Central Nervous System Through MR Susceptibility-Weighted Imaging
por: Zhang, Ni, et al.
Publicado: (2021)

Central Nervous System Infections
por: Archibald, Lennox K., et al.
Publicado: (2013)

Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system?
por: De Bock, Marijke, et al.
Publicado: (2013)

The Emerging Role of Extracellular Vesicle Derived From Neurons/Neurogliocytes in Central Nervous System Diseases: Novel Insights Into Ischemic Stroke
por: Li, Fan, et al.
Publicado: (2022)

Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
por: Principi, Nicola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v1hruk1omopfrirguhjnpaoa2m